Introduction {#s1}
============

An outbreak of atypical pneumonia (Coronavirus Disease 2019, COVID-19) caused by the novel coronavirus (2019-nCoV) emerged in Wuhan, China, at the end of 2019. The virus rapidly spread across China and the rest of the world. As of 9 May, 83,976 confirmed infections and 4,639 deaths had been reported within China[^1^](#fn0001){ref-type="fn"}^,^[^2^](#fn0002){ref-type="fn"}. The majority of cases in China have been identified in Hubei Province, especially within Wuhan. The Wuhan Municipal Government began a citywide lockdown on 23 January 2020 to slow the spread of the disease, and other cities in Hubei Province soon followed suit[^3^](#fn0003){ref-type="fn"}. The lockdown effectively curbed further exportation of the epidemic from Hubei to the other provinces of China ([@B1]--[@B4]). Within China, the outbreak has been effectively under control and the main effort was put in identifying the imported cases from overseas[^1^](#fn0001){ref-type="fn"}. However, the WHO declared COVID-19 a global pandemic on 11 March due to its spread and severity worldwide, with 2,361,998 confirmed infections and 272,094 deaths outsides China as of 9 May.

Mathematical modelling, including statistical modelling, is a useful tool to understand the dynamics of new diseases. Since COVID-19 was first identified, many mathematical models have been developed to simulate the transmission across populations and assess the potential impact of public health interventions. Crucial parameters of new diseases can be derived from models, including the basic reproduction number (R~0~), peak time, peak size, incubation period, infectious period, case-fatality rate (CFR), and elimination time. By definition, R~0~ measures the average number of secondary cases that are expected to be generated from a single case of a disease entering a completely susceptible population ([@B5]). R~0~ decreases if intervention measures are implemented or the susceptible population size decreases. The controlled reproduction number (R~c~) denotes R~0~ after interventional measures are undertaken. If R~0~ \< 1, then one infectious person will infect fewer than one person, and an epidemic will ultimately resolve ([@B6]). Thus, R~0~ is an important parameter to assess potential control strategies during an outbreak. Peak time refers to the time when a disease infects the largest number of people (peak size) and is an inflection point during an outbreak.

Published models of COVID-19 have reported a huge range of estimated R~0~ and peak times. For example, Zhang et al. ([@B7]) estimated an R~0~ of 1.44 while Mizumoto et al. ([@B8]) reported an R~0~ of 7.05. To better inform efforts to control the current outbreak, we systematically reviewed existing mathematical and statistical models and built our own mathematical model to estimate the transmission capacity, epidemiological characteristics, potential peak time and size, and elimination time of COVID-19.

Methods {#s2}
=======

Search Strategy and Selection Criteria
--------------------------------------

Our systematic review was conducted according to PRISMA guidelines ([@B9]). We searched PubMed, Web of Science, EMBASE, bioRxiv, medRxiv, arXiv, Preprints, and National Knowledge Infrastructure (CNKI) for studies published between 1 December 2019 and 21 February 2020. We used the search terms "Coronavirus Disease 2019," "COVID-19," "SARS-CoV-2," "2019-nCoV," "coronavirus," OR "pneumonia" AND "model," "modelling," "modeling," "dynamic," "estimation," "prediction," OR "transmission." Search terms were translated into Chinese when searching Chinese database. The database search was supplemented by screening references of retrieved articles.

Studies were included if they presented a mathematical/statistical model of COVID-19 and reported any of the following---R~0~, incubation period, infectious period, fatality, peak time, peak size, total infection number, or elimination time. Studies were excluded if they were purely methodological and did not report the aforementioned parameters. If one study was concurrently published in a journal and preprint website, only the journal version was included. Two reviewers (YL and YZ) independently performed the literature search and screened titles and abstracts. Disagreements were resolved by discussion among all authors.

Data Analysis
-------------

Data extraction was performed by QD, Y-FL, and YZho independently, and results were summarised by Y-FL. Abstracted variables included the first author, model type, type and period of data used for model fitting, setting, region of interest, estimated R~0~, estimated incubation period, estimated CFR, estimated peak time and peak size, and impact of outbreak response if available. Assumed values of the incubation period based on other studies were excluded. Quality of mathematical models was assessed according to a quality-appraisal tool developed upon the recommendations by the International Society for Pharmacoeconomics and Outcomes Research and Society for Medical Decision Making (ISPOR-SMDM) Modelling Good Research Practices Task Force ([@B10], [@B11]). Such a tool brings up questions regarding 14 criteria, e.g., model setting and population, modelling methodology and structure, and fitting methodology (see Appendix in [Supplementary Material](#SM1){ref-type="supplementary-material"}). Each criterion of a paper was scored zero, one, or two. If a criterion was not relevant for a paper, then a score of one was assigned. QD, Y-FL, and YZho assessed the quality of mathematical models, and discrepancies were resolved through discussion with a senior investigator (HZo).

A comprehensive meta-analysis of extracted data was not performed due to the high level of heterogeneity between the studies in terms of model type, model setting, type and period of data used for model calibration, and region of interest. However, some key parameters were analysed, including estimated parameters (R~0~/R~c~, incubation period, infectious period, and CFR) and model predictions (peak size and peak time, total infections, and elimination time). R~0~/R~c~ was analysed by stratifying regions, namely "Wuhan," "Hubei (including Wuhan)," "mainland China (excluding Taiwan, Hong Kong and Macau)," and "regions other than Hubei in mainland China."

We reported distributions of point estimates and reported medians and interquartile ranges (IQR). We did not pool point estimates from various mathematical models. Categorical variables were presented as frequencies or proportions. Data were combined by interval segments and/or grouped by the same characteristics according to the sparsity of data. Some statistical methods, mainly non-parametric methods, including the Wilcoxon rank sum test (R~0~/R~c~), Kruskal-Wallis H test (regions), and Quade test (R~0~/R~c~ and regions), were used to analyze differences between segments/groups.

We modelled COVID-19 transmission using a classic susceptible (S)-exposed (E)-infectious (I)-recovery (R) (SEIR) structure model (see Appendix in [Supplementary Material](#SM1){ref-type="supplementary-material"}) to predict future trends and expected peak time in Wuhan. Two assumptions were separately considered in this SEIR model: (1) individuals in the incubation period are infectious and (2) individuals in the incubation period are not infectious. We used the parameter values that were obtained from our review of previous models for our model simulations. When calibrating the model, the top 20 of 256 best-fit simulations, selected by least square error, were used to obtain estimates of epidemic trends. We calculated peak times and eliminations (total infections \<100) based on normal (median), optimistic, and pessimistic scenarios. All analyses were conducted with R software version 3.6.2 (R Foundation for Statistical Computing). Confirmed reported cases between 12 February 2020 and 21 February 2020 were downloaded from the China National Health Commission website [^1^](#fn0001){ref-type="fn"}.

Results {#s3}
=======

We identified 1,451 studies; 269 were duplicates, which left us with 1,182 unique studies ([Figure 1](#F1){ref-type="fig"}). After screening titles and abstracts, 90 studies underwent a full-text review. Of these, 38 were excluded because they did not report necessary parameters or were not models specifically targeting COVID-19. Fifty-two publications were eligible for inclusion. Details of each included study is summarised in the Appendix ([Supplementary Material](#SM1){ref-type="supplementary-material"}) ([@B4], [@B7], [@B8], [@B12]--[@B36]).

![Selection of reports for inclusion in systematic review. Coronavirus Disease 2019, COVID-19; R0, the basic reproduction number.](fmed-07-00321-g0001){#F1}

The 52 included studies reported a total of 75 unique models, including 88% (66/75) of articles calibrated models using original data (i.e., reported cases), 7% (5/75) used adjusted data modified by reported rates prior to model fitting, and 5% (4/75) articles used simulations. 35% (26/75), 16% (12/75), 37% (28/75), and 12% (9/75) of models refer to Wuhan, Hubei, mainland China, and regions other than Hubei in mainland China. The other regions mentioned in these nine articles were too wide, such as Guangdong Province, Beijing, and Chongqing, so we decided to focus on the first three regions only. The usage frequency of different models is summarised in the Appendix ([Supplementary Material](#SM1){ref-type="supplementary-material"}).

Thirty studies reported estimated R~0~ and/or R~c~. Models used to generate R~0~/R~c~ varied in terms of model type, model structure, model setting, and data used for model fitting (see Appendix in [Supplementary Material](#SM1){ref-type="supplementary-material"}). R~0~ differed significantly before and after the citywide lockdown in Wuhan ([Figures 2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}, *p* \< 0.001). The median R~0~ was 3.77 (IQR, 2.78--5.13), and median R~c~ was 1.88 (IQR, 1.41--2.24). After aggregating data by regions, median R~0~ for Wuhan, Hubei, and mainland China over the whole outbreak period were 3.16 (IQR, 2.36--4.40), 4.39 (IQR, 3.18--5.15), and 3.03 (IQR, 2.30--4.19), respectively. Differences between these estimated R~0~ were not statistically significant (*p* = 0.180).

![The basic reproduction number (R0) and controlled reproduction number (Rc) estimated among models. CI, confidence interval; M1, model 1; M2, model 2; S1, scenario 1; S2, scenario 2; Other, regions other than Hubei in China.](fmed-07-00321-g0002){#F2}

![Distribution of the basic reproduction number (R0) and controlled reproduction number (Rc) estimated among models. Other, regions other than Hubei in China.](fmed-07-00321-g0003){#F3}

When R~0~ and R~c~ were stratified by region, differences in R~0~ and R~c~ remained statistically significant across all four regions. In Wuhan, the median of R~0~ was 3.22 (IQR, 2.50--5.03) and R~c~ was 2.09 (IQR, 1.95--2.96). In Hubei, the median R~0~ and R~c~ were 4.80 (IQR, 4.07--5.58) and 1.48 (IQR, 1.01--2.08), respectively. Across mainland China, R~0~ was 3.55 (IQR, 3.03--4.66), and the median R~c~ was 2.19 (IQR, 1.76--2.48).

Nineteen studies predicted peak time and peak size of infections. Estimates varied from late January to late March with peak size ranging from 7,000 to 90,000 ([Table 1](#T1){ref-type="table"}). Elimination time was predicted in five studies, with estimates ranging from March to August 2020 ([@B7], [@B37]--[@B40]).

###### 

Peak time/size and elimination time predicted in models.

  **First author**   **Model**                                      **Peak time**                                                        **Peak size**             **Elimination**               **Location**
  ------------------ ---------------------------------------------- -------------------------------------------------------------------- ------------------------- ----------------------------- ----------------------------------------
  Zhu                ODE based: SIR model                           Still goes up/10 February/middle or late with work/school resuming   NA                        NA                            Other[^\*^](#TN1){ref-type="table-fn"}
  Wang               ODE based: SIR model                           10 March                                                             NA                        NA                            China
  Wu                 ODE based: SIR model                           17 March                                                             NA                        NA                            Other
  Xiong              ODE based: EIR model (100% Quarantined rate)   16 February                                                          49,093                    NA                            China
  Xiong              ODE based: EIR model (90% Quarantined rate)    17 February                                                          51,605                    NA                            China
  Xiong              ODE based: EIR model (80% Quarantined rate)    18 February                                                          55,059                    NA                            China
  Xiong              ODE based: EIR model (70% Quarantined rate)    19 February                                                          59,953                    NA                            China
  Xiong              ODE based: EIR model (63% Quarantined rate)    20 February                                                          64,740                    NA                            China
  Tang               ODE based: SEIR model                          10 February                                                          163,000                   NA                            China
  Wang               ODE based: SEIR model (R~0~ = 0.5)             5 February                                                           11,966                    NA                            China
  Wang               ODE based: SEIR model (R~0~ = 0.25)            4 February                                                           11,373                    NA                            China
  Wang               ODE based: SEIR model (R~0~ = 0.125)           3 February                                                           11,116                    Early May                     China
  Wu                 ODE based: SEIR model                          April                                                                NA                        NA                            Wuhan
  Wu                 ODE based: SEIR model                          Mid-February                                                         NA                        NA                            China
  Ai                 ODE based: SEIR model                          28 January−7 February                                                7,000--9,000              NA                            Hubei
  Peng               ODE based: SEIR model                          NA                                                                   NA                        Beginning April               Wuhan
  Peng               ODE based: SEIR model                          NA                                                                   NA                        Mid-March                     Hubei
  Wan                ODE based: SEIR model                          19 February                                                          45,000                    Late March                    Wuhan
  Wan                ODE based: SEIR model                          9 March (2--24 March)                                                313,00 (27,700--36,800)   NA                            China (without Hubei)
  Wan                ODE based: SEIR model                          3 March (27 February−18 March)                                       63,800 (59,300--76,500)   NA                            Hubei
  Li                 ODE based: SEIR model                          10 March (19 February−30 March)                                      NA                        NA                            Wuhan
  Li                 ODE based: SEIR model                          31 March (15 March−16 April)                                         NA                        NA                            Other
  Liu                ODE based: Flow-SEIR model                     9 March (2--24 March)                                                85,500 (76,700--97,500)   1.5--2 months from the peak   China
  Liu                ODE based: Flow-SEIR model                     29 February (25 February−8 March)                                    62,800 (56,900--70,300)   1.5--2 months from the peak   Hubei
  Shen               ODE based: SEIJR model (isolation)             Early-March (1 March)                                                827 (421--1232)           NA                            China
  Shen               ODE based: SEIJR model (lockdown)              17 February (14--27 February)                                        12,143 (5,872--19,852)    NA                            China
  Zeng               ODE based model                                NA                                                                   NA                        28 February                   China
  Zeng               ODE based model                                NA                                                                   NA                        10 March                      China
  Zeng               ODE based model                                NA                                                                   NA                        29 February                   China
  Zeng               ODE based model                                NA                                                                   NA                        24 February                   China
  Zeng               ODE based model (NN-−1day delay)               NA                                                                   NA                        28 February                   China
  Zeng               ODE based model (NN-−2 days delay)             NA                                                                   NA                        3 March                       China
  Zeng               ODE based model (NN---no policies)             NA                                                                   NA                        28 April                      China
  Batista            Probabilistic/likelihood-based model           4 February                                                           NA                        NA                            China
  Batista            Probabilistic/likelihood-based model           22 August                                                            NA                        NA                            China
  Hermanowicz        EG model                                       7--20 February                                                       65,000                    NA                            China
  Liu                EG model                                       4 February                                                           NA                        NA                            Wuhan

*Other regions other than Hubei in China*.

*ODE, Ordinal Differential Equation; SIR, Susceptible-Infected-Recovered; EIR, Exposed-Infectious-Recovered; SEIR, Susceptible-Exposed-Infectious-Recovered; SEIJR, Susceptible-Exposed-Infectious-Isolated-Recovered; EG, Exponential Growth; R~0~, the reproduction number*.

Incubation period was estimated in 9 studies, with the median estimate being 5.90 days (IQR 4.78--6.25) ([@B3], [@B7], [@B20], [@B22], [@B28], [@B41]--[@B44]). Among the six studies reporting infection period, the median estimate was 9.94 days (IQR, 3.93--13.50) \[[Figure 4](#F4){ref-type="fig"}; ([@B7], [@B14], [@B15], [@B17], [@B25])\]. Six studies reported CFR, and median estimated CFR was 2.94% (IQR, 2.25%−5.40%) ([@B3], [@B8], [@B15], [@B20], [@B22], [@B31]).

![Incubation, case-fatality rate, and infectious period estimates among models. **(A)** incubation period; **(B)** fatality; **(C)** infectious period. CI, confidence interval; S1, scenario 1; S2, scenario 2.](fmed-07-00321-g0004){#F4}

The estimated number of total infections varied by region (see Appendix in [Supplementary Material](#SM1){ref-type="supplementary-material"}). Median estimated number of total infections in Wuhan, Hubei, and mainland China were 56,565 (IQR, 49,795--280,255), 61,028 (IQR, 43,750--111,682), and 87,525 (IQR, 59,784--461,652), respectively ([@B3], [@B8], [@B15], [@B17], [@B20], [@B38], [@B39], [@B45]--[@B48]). Most studies used data from 23 January 2020 or earlier when building models. Two thirds of studies that predicted abnormally high totals came from Probabilistic/likelihood-based models that used data from after 23 January 2020 ([@B15], [@B46], [@B48]).

The estimated impact of interventions is summarised in the Appendix ([Supplementary Material](#SM1){ref-type="supplementary-material"}). Four of 10 studies found that after implementing citywide lockdown in Wuhan, R~0~ would be reduced by 87--95%, peak size would be reduced by 21.06--22.38%, and deaths would be reduced by 56.87--62.95% ([@B1]--[@B4]). Three studies predicted delay of lockdown measures by 1 or 7 days would increase the number of infections at peak size by 722--6,351 and 8,618--28,274, respectively ([@B3], [@B16], [@B49]). Increasing diagnosis efficacy to 70% was predicted to reduce infections by 90% as of 10 February 2020 ([@B50]).

We generated models under two separate assumptions: (A1) individuals are infectious during the incubation period and (A2) individuals are not infectious during the incubation period. In the A1 model, mean R~c~ was 2.15 (SD, 0.15); mean incubation period was 5.19 days (SD, 0.53); mean infectious period was 11.87 days (SD, 1.35); and CFR was 2.68% (SD, 0.67%). In the A2 model, mean R~c~ was 2.14 (SD, 0.16); mean incubation period was 5.17 days (SD, 0.50); mean infectious period was 12.00 days (SD, 1.51); and CFR was 2.43% (SD, 0.39%). Mean of least square error in the top 20 best-fit simulations was 17,944 (SD, 1,140) and 27,750 (SD, 1,754) in the A1 and A2 models, respectively (see Appendix in [Supplementary Material](#SM1){ref-type="supplementary-material"}).

The top 20 best-fit simulations with best- and worst-case scenarios are presented in [Figure 5](#F5){ref-type="fig"}. In the A1 model, R~c~, peak size was 55,225 and 188,284 in the best- and worst-case scenarios, respectively. In the A2 model, peak size was 28,237 and 36,248 in the best- and worst-case scenarios, respectively. In Wuhan, the A1 model predicted peak time would be 17 March (Range, 12--22 March 2020), and elimination time would be 7 May (25 April−21 May 2020). In the A2 model, peak time was estimated to be 2 March (Range, 13 February−5 March 2020) and elimination time to be 17 May (8--27 May 2020).

![Estimates of peak time and elimination time in SEIR model. SEIR, susceptible-exposed-infectious-recovered.](fmed-07-00321-g0005){#F5}

Discussion {#s4}
==========

Our systematic review and data synthesis is the first study to synthesize mathematical models on the transmission of COVID-19. The estimated values of R~0~, incubation period, infectious period, peak time, and peak size for COVID-19 were consistently higher than that of SARS or MERS, suggesting this novel coronavirus is highly infectious. We also found that the citywide lockdown of Wuhan resulted in significantly reduced R~0~, with the earliest elimination time in China now estimated to be late April, though the complex dynamics of an evolving global pandemic were not incorporated into included models.

In this systematic review of transmission-dynamic models predicting the spread of COVID-19, we found the median estimated R~0~ to be 3.77, suggesting this novel virus is highly infectious. Estimated R~0~ of COVID-19 was higher than that of middle east respiratory syndrome coronavirus (MERS-CoV, \<1) and severe acute respiratory syndrome (SARS, 2--4) ([@B51], [@B52]). This corresponds to the difference between the total number of infections seen in the current COVID-19 and 2003--2004 SARS outbreaks in China (\>80,000 vs. \~5,327)[^1^](#fn0001){ref-type="fn"}.

After a citywide lockdown began in Wuhan, the median estimated R~c~ dropped to 1.88, suggesting a large drop in infections coincided with the implementation of this outbreak control intervention. By limiting interactions and preventing travel, the lockdown effort has dramatically reduced contact rates between infected and non-infected persons. However, an R~c~\>1 suggests that COVID-19 would continue to spread, which is at odds with recently published epidemiological reports, suggesting the outbreak in China is slowing down[^1^](#fn0001){ref-type="fn"}. This discrepancy may suggest that other recently implemented public health measures beyond citywide lockdowns, including contact tracing, intensification of screening, quarantine of infected individuals, and mask utilisation, may also be contributing to the containment of COVID-19. Future models should attempt to capture the impact of these additional interventions on COVID-19 transmission.

We found median estimated incubation period, infectious period, and fatality were 5.90 days, 9.94 days, and 2.94%, respectively. If these estimations are accurate, a 14-day quarantine period would be long enough to assess for infection in an asymptomatic person exposed to COVID-19. It should be noted that the maximum incubation period reported for COVID-19 was 24 days, and additional research is needed to confirm these estimations. However, this estimated incubation period is similar to that of SARS and MERS ([@B51], [@B52]). Estimated CFR of COVID-19 (2.94%) was substantially lower than that of SARS (14--15%) and MERS (34.4%), suggesting COVID-19 may be a less virulent strain in the coronavirus family ([@B20], [@B22], [@B51], [@B53]). As of 9 May, the epidemic in China has almost come to end and local asymptomatic infected cases have been captured by the surveillance system, with the death toll come to 4,643 and fatality rate about 5.5%.

We found significant variation in estimated R~0~ and R~c~ in our review of the published literature. These variations may be due to the wide variety of modelling methods used and different assumptions used to build each model. Additionally, limited healthcare resources and immature diagnostic algorithms resulted in under-diagnosis and delayed treatment at the beginning of the outbreak in Wuhan. Consequently, models calibrated using only the official number of confirmed infections may be impacted by a systematic underreporting of infections, leading to a higher estimated R~0~ compared to models that adjusted for potential underreporting. Several studies included in this review concluded that underreported infections may have had an significant impact on estimated R~0~ ([@B15], [@B21], [@B54]), and five studies attempted to approximate the number of unreported cases ([@B13], [@B18], [@B21], [@B22], [@B24]).

Our mathematical model predicts peak time for COVID-19 will be in March 2020 and elimination is likely to be achieved by late April 2020 at the earliest, assuming the current intervention level is maintained. This estimate of peak time is close to the reality that there are few locally infected cases after 31 March, which indicates that the peak size of local transmission has been reached in March. Elimination of local transmission has been achieved in April as most of newly infected cases are imported from overseas. COVID-19 continues to spread worldwide[^2^](#fn0002){ref-type="fn"} ([@B55]), and the influx of overseas cases may introduce new transmission dynamics that are not possible to predict using current models. Studies have reported that the epidemic of some viruses (e.g., SARS-CoV) or bacteria (e.g., *Clostridioides difficile*) can be affected by geographical climatic factors such as temperature, humidity, and latitude ([@B56]--[@B58]), and COVID-19 infections may consequently be impacted by seasonality and latitude in unpredictable ways. However, we were not able to add additional results and analysis of temperature for COVID-19 due to lack of available data. In addition, the difference in social mixing pattern between rural and urban areas may lead to different transmission models. These data are essential to a thorough understanding of the spread of SARS-CoV-2 and formulating appropriate intervention strategies. Through comparing the two scenarios of our mathematical model, scenarios with an infectious incubation period resulted in much better goodness-of-fit. This to some extent support that incubation period is infectious. Finally, the potential impact of new treatment or vaccines for COVID-19 are not represented in the predictions of our models.

Our study has limitations. First, some studies included multiple models, and, as a result, models developed with certain underlying assumptions and validation methods were overrepresented in our results. Second, none of the included models considered age-related contact rates. Immunity to and fatality from COVID-19 likely differ across age cohorts. Without accounting for this key difference, results of all included models should be interpreted with caution. Third, our synthesis model did not take into account rates of underreported infections, additional quarantine efforts, mask usage, or changes in mass transportation, which may change our predictions. Without readily available data effects of these factors are hard to account for.

Findings from our systematic review and mathematical model suggest high infectiousness of COVID-19, and the lockdown of Wuhan significantly reduced R~0~. If current modelling is accurate, a 14-day quarantine is sufficient for asymptomatic persons exposed to the virus. The effect of age on infection and fatality should be incorporated into future models to more accurately predict transmission dynamics. Interventions besides citywide lockdowns, including mask utilisation and travel restrictions, should be further evaluated through modelling in order to better inform ongoing efforts to contact outbreaks inside and outside China.
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